Xinlitai (002294.SZ): SAL0145 drug clinical trial application accepted

Zhitongcaijing · 5d ago

Zhitong Finance App News, Xinlitai (002294.SZ) announced that the company received an acceptance notice approved and issued by the State Drug Administration, and the clinical trial application for the innovative drug SAL0145 injection (project code: SAL0145) independently developed by the company was accepted.

According to the announcement, SAL0145 is a siRNA drug with independent intellectual property rights developed by the company. The application submitted by the company is a clinical trial application for SAL0145 for the treatment of MASH.